COVID-19 and metabolic diseases: a heightened awareness of health inequities and a renewed focus for research priorities.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 33581046.
- Also identified by DOI 10.1016/j.cmet.2021.02.006 and PMC identifier 7869609.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Chronic metabolic disorders such as diabetes and obesity are major public health issues in the United States. However, significant disparities in their prevalence and incidence place a greater burden on US racial and ethnic minority groups, contributing to worse COVID-19 outcomes in many. Improving treatment and prevention of diabetes and obesity is critical to the NIDDK. In this Perspective, we will review the burden of metabolic diseases in the United States, the observed disparities for metabolic diseases in relation to COVID-19, and research opportunities to address underlying causes of metabolic diseases, their associated health disparities, and COVID-19.
Medical subject headings
- COVID-19
- Diabetes Mellitus
- Healthcare Disparities
- Metabolic Diseases
- Obesity